Morning Briefing
Summaries of health policy coverage from major news organizations
EU-India Free-Trade Negotiations Could Limit Access To Affordable, Generic Drugs, Advocacy Group Says
The advocacy group Medecins Sans Frontieres (MSF) recently warned that free-trade negotiations between the EU and India could limit access to "affordable generic drugs" for people in India and the rest of the developing world, Reuters reports. "Back in 2005 India granted patents on medicines to respect international trade rules and MSF said a new free-trade agreement now under negotiation would tighten these rules," the news service writes. The EU said it has not requested that India stop producing low-cost generic drugs.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
